Chinese translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

Tombal, Bertrand; Farrington, Thomas; Muslin, David; Manarite, Jan; Crawford, David; Sternberg, Cora N.; Fizazi, Karim; Saad, Fred; Hussain, Maha; Smith, Matthew R.

doi:10.25402/FON.22041332.v2

Chinese QR.pdf (4.29 MB)

Chinese translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

journal contribution

posted on 2023-03-15, 12:54 authored by Bertrand Tombal, Thomas Farrington, David Muslin, Jan Manarite, David Crawford, Cora N. Sternberg, Karim Fizazi, Fred Saad, Maha Hussain, Matthew R. Smith

Chinese translation

History

Usage metrics

Keywords

urological/prostate safety plain language summary overall survival novel therapy metastatic hormone-sensitive prostate cancer lay summary drug development darolutamide

Licence

CC BY-NC-ND 4.0

Chinese translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

History

Usage metrics

Categories

Keywords

Licence

Exports